The invention relates to a pharmaceutical composition according to the claim 1 comprising a glucopyranosyl-substituted benzene derivative in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
该发明涉及根据权利要求1的药物组合物,包括一种
葡萄糖吡喃基取代苯衍
生物与一种适用于治疗或预防从以下选定的一种或多种疾病的
DPP IV
抑制剂的组合物,所述疾病包括1型糖尿病、2型糖尿病、糖耐量受损和高血糖。此外,本发明涉及预防或治疗代谢紊乱及相关疾病的方法。